218 related articles for article (PubMed ID: 17011754)
1. Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients.
Torti C; Lapadula G; Uccelli MC; Quiros-Roldan E; Regazzi M; Ladisa N; Micheli V; Orani A; Patroni A; Caputo SL; Tirelli V; Di Giambenedetto S; Cologni G; Costarelli S; Gargiulo F; Manca N; Carosi G;
Int J Antimicrob Agents; 2007 Feb; 29(2):185-90. PubMed ID: 17011754
[TBL] [Abstract][Full Text] [Related]
2. Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?
Cicconi P; Cozzi-Lepri A; Phillips A; Puoti M; Antonucci G; Manconi PE; Tositti G; Colangeli V; Lichtner M; Monforte Ad;
AIDS; 2007 Mar; 21(5):599-606. PubMed ID: 17314522
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection.
Asmuth DM; Busch MP; Laycock ME; Mohr BA; Kalish LA; van der Horst CM;
Antiviral Res; 2004 Aug; 63(2):123-31. PubMed ID: 15302141
[TBL] [Abstract][Full Text] [Related]
4. [Chronic hepatitis B and C in HIV-infected patients].
Opravil M; Hunziker R; Lüthy R; Grob PJ
Dtsch Med Wochenschr; 1998 Jun; 123(24):753-60. PubMed ID: 9672477
[TBL] [Abstract][Full Text] [Related]
5. Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database.
Petoumenos K; Ringland C;
HIV Med; 2005 May; 6(3):155-63. PubMed ID: 15876281
[TBL] [Abstract][Full Text] [Related]
6. Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis.
Martín-Carbonero L; Barreiro P; Jiménez-Galán G; García-Berriguete R; Núñez M; Ríos P; González-Lahoz J; Soriano V
J Viral Hepat; 2007 Jun; 14(6):392-5. PubMed ID: 17501759
[TBL] [Abstract][Full Text] [Related]
7. Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.
Omland LH; Weis N; Skinhøj P; Laursen A; Christensen PB; Nielsen HI; Møller A; Engsig F; Sørensen HT; Obel N
HIV Med; 2008 May; 9(5):300-6. PubMed ID: 18400077
[TBL] [Abstract][Full Text] [Related]
8. Hepatic safety profile of raltegravir in HIV-infected patients with chronic hepatitis C.
Vispo E; Mena A; Maida I; Blanco F; Cordoba M; Labarga P; Rodriguez-Novoa S; Alvarez E; Jimenez-Nacher I; Soriano V
J Antimicrob Chemother; 2010 Mar; 65(3):543-7. PubMed ID: 20032006
[TBL] [Abstract][Full Text] [Related]
9. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
[TBL] [Abstract][Full Text] [Related]
10. Liver enzymes elevation after HAART in HIV-HCV co-infection.
Servin-Abad L; Molina E; Baracco G; Arosemena L; Regev A; Jeffers L; Schiff E
J Viral Hepat; 2005 Jul; 12(4):429-34. PubMed ID: 15985015
[TBL] [Abstract][Full Text] [Related]
11. Favourable one-year ART outcomes in adult Malawians with hepatitis B and C co-infection.
Moore E; Beadsworth MB; Chaponda M; Mhango B; Faragher B; Njala J; Hofland HW; Davies J; Hart IJ; Beeching NJ; Zijlstra EE; van Oosterhout JJ
J Infect; 2010 Jul; 61(2):155-63. PubMed ID: 20470823
[TBL] [Abstract][Full Text] [Related]
12. The prevalence and risk of hepatitis flares in a Serbian cohort of HIV and HCV co-infected patients treated with HAART.
Jevtović Dj; Ranin J; Salemović D; Pesić I; Dragović G; Zerjav S; Djurković-Djaković O
Biomed Pharmacother; 2008 Jan; 62(1):21-5. PubMed ID: 17223307
[TBL] [Abstract][Full Text] [Related]
13. [Morphological liver changes of chronic hepatitis C in antiretroviral-naive HIV-infected patients].
Grabczewska E; Pawłowska M
Przegl Epidemiol; 2005; 59(2):423-30. PubMed ID: 16190550
[TBL] [Abstract][Full Text] [Related]
14. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.
Phillips E; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS
AIDS; 2007 Jul; 21(12):1561-8. PubMed ID: 17630551
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology and natural history of HIV/HBV and HIV/HCV co-infections.
Mathews G; Bhagani S
J HIV Ther; 2003 Nov; 8(4):77-84. PubMed ID: 14671504
[TBL] [Abstract][Full Text] [Related]
16. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study.
Sheng WH; Hung CC; Kao JH; Chang SY; Chen MY; Hsieh SM; Chen PJ; Chang SC
Clin Infect Dis; 2007 Apr; 44(7):988-95. PubMed ID: 17342655
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of conditions associated with human immunodeficiency and hepatitis virus infections among persons with haemophilia, 2001-2003.
Goedert JJ;
Haemophilia; 2005 Sep; 11(5):516-28. PubMed ID: 16128897
[TBL] [Abstract][Full Text] [Related]
18. Chronic hepatitis B and other correlates of spontaneous clearance of hepatitis C virus among HIV-infected people with hemophilia.
Melendez-Morales L; Konkle BA; Preiss L; Zhang M; Mathew P; Eyster ME; Goedert JJ
AIDS; 2007 Jul; 21(12):1631-6. PubMed ID: 17630559
[TBL] [Abstract][Full Text] [Related]
19. High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?
Bani-Sadr F; Goderel I; Morand P; Payan C; Lunel F; Pol S; Perronne C; Carrat F; Cacoub P
AIDS; 2007 Jul; 21(12):1645-8. PubMed ID: 17630563
[TBL] [Abstract][Full Text] [Related]
20. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men.
Colin JF; Cazals-Hatem D; Loriot MA; Martinot-Peignoux M; Pham BN; Auperin A; Degott C; Benhamou JP; Erlinger S; Valla D; Marcellin P
Hepatology; 1999 Apr; 29(4):1306-10. PubMed ID: 10094979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
